Invivo CAR-T combined (IMAGE)
Caption
The Johns Hopkins-developed nanoparticles were able to induce the destruction of the majority of the immune system cells called B cells, which contribute to diseases such as lupus and cancers of the blood. Top image: Blue dyed B cells in the spleen of an untreated mouse. Bottom image: Reduction of blue B cells in the spleen of a mouse treated with the nanoparticles.
Credit
Manav Jain and Jordan Green, Johns Hopkins Medicine
Usage Restrictions
none
License
Original content